RxDoctor Payments DataLook up a doctor →

Megan Cundiff, PA

Physician Assistant · Mount Pleasant, SCNPI 1679128276

Payments from drug & device makers

$14,406in general payments, 2019–2025

Across 815 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$1K
  • Lilly USA, LLC$1K
  • Pfizer$943
  • AstraZeneca$857
  • Axsome Therapeutics, Inc.$766
  • plus $8K from 54 others

What the payments were for

  • Food & beverage$14,406100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk102$1,563
AbbVie(2 entities)119$1,362
Lilly USA, LLC80$1,114
Pfizer68$943
AstraZeneca(2 entities)27$857
Axsome Therapeutics, Inc.35$766
Amgen(2 entities)39$654
Esperion Therapeutics, Inc.28$553
Corium, LLC23$422
Biohaven Pharmaceuticals, Inc.12$406
Johnson & Johnson14$392
Lundbeck LLC18$360
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC21$357
GSK15$354
Takeda Pharmaceuticals U.S.A., Inc.16$341
Boehringer Ingelheim17$279
Novartis13$232
Biohaven Pharmaceutical Holding Company Ltd.12$224
Otsuka America Pharmaceutical, Inc.11$223
Dexcom, Inc.7$221
Exact Sciences10$187
Amarin Pharma, Inc.13$181
Bayer9$163
Antares Pharma, Inc.8$159
Paratek Pharmaceuticals, Inc.8$149
Astellas Pharma US Inc7$147
Teva Pharmaceuticals USA, Inc.8$140
Akcea Therapeutics, Inc.1$125
Supernus Pharmaceuticals, Inc.6$121
Gilead1$121
Genentech USA, Inc.3$115
Idorsia Pharmaceuticals US Inc6$97
Sanofi-aventis U.S. LLC3$92
Alnylam Pharmaceuticals Inc.4$80
Eisai Inc.5$78
Noven Therapeutics, LLC3$65
Radius Health, Inc.3$65
Jazz Pharmaceuticals Inc.3$65
Daiichi Sankyo Inc.3$63
E.r. Squibb & Sons, L.L.C.3$51
Corcept Therapeutics2$47
Ultragenyx Pharmaceutical Inc.2$43
Clarus Therapeutics Inc.3$31
Merck2$31
Vanda Pharmaceuticals Inc.1$31
Adlon Therapeutics L.p.2$30
Halozyme Inc1$29
Neos Therapeutics, LP2$29
Kyowa Kirin, Inc.1$28
Ardelyx, Inc.1$26
Phathom Pharmaceuticals, Inc.3$24
Nabriva Therapeutics, PLC1$20
Abbott1$20
Currax Pharmaceuticals LLC1$18
Sumitomo Pharma America, Inc.1$17
Harmony Biosciences LLC1$15
Renalytix AI, Inc.1$15
Tolmar, Inc.1$15
Biogen1$14
Acerus Pharmaceuticals Corporation1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,406 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$81,350
Medicare patients
277
Services billed
1,995

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide70$112,880
EliquisApixaban39$36,140
MounjaroTirzepatide25$35,447
FarxigaDapagliflozin Propanediol25$27,026
JardianceEmpagliflozin17$24,030
Repatha SureclickEvolocumab20$19,405
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$18,705
Tresiba Flextouch U-200Insulin Degludec25$15,111
XareltoRivaroxaban13$12,936
Aimovig AutoinjectorErenumab-Aooe11$7,584
Tresiba Flextouch U-100Insulin Degludec14$7,196
Rosuvastatin Calcium117$1,826
Albuterol Sulfate HfaAlbuterol Sulfate51$1,423
Valsartan23$1,145
Celecoxib29$1,141

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,563$112,88070 claims
PfizerEliquis$943$36,14039 claims
Lilly USA, LLCMounjaro$1,114$35,44725 claims
AstraZenecaFarxiga$857$27,02625 claims
Boehringer IngelheimJardiance$279$24,03017 claims
GSKTrelegy Ellipta$354$18,70515 claims
Johnson & JohnsonXarelto$392$12,93613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Mount Pleasant

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →